Mary M. Sugrue
- Oncology top 2%
- Molecular Biology top 10%
- Pulmonary and Respiratory Medicine top 5%
- Hepatology top 2%
- Physiology top 10%
- Co-authors
- Stuart A. AaronsonAxel GrotheyMark KozloffWei DongDavid M. PurdieSam W. LeeEric HedrickDaniel J. Sargent
- Topics
- Colorectal Cancer Treatments and Studies (16 papers)Acute Myeloid Leukemia Research (15 papers)Cancer Treatment and Pharmacology (12 papers)
- Partner nations
- United StatesFranceGermany
In The Last Decade
Mary M. Sugrue
47 papers receiving 2.2k citations
Hit Papers
Peers
Comparison fields: 5 of 103
- Oncology 1.3k
- Molecular Biology 929
- Pulmonary and Respiratory Medicine 474
- Hepatology 296
- Physiology 239
Countries citing papers authored by Mary M. Sugrue
This map shows the geographic impact of Mary M. Sugrue's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mary M. Sugrue with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mary M. Sugrue more than expected).
Fields of papers citing papers by Mary M. Sugrue
This network shows the impact of papers produced by Mary M. Sugrue. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mary M. Sugrue. The network helps show where Mary M. Sugrue may publish in the future.
Co-authorship network of co-authors of Mary M. Sugrue
This figure shows the co-authorship network connecting the top 25 collaborators of Mary M. Sugrue. A scholar is included among the top collaborators of Mary M. Sugrue based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mary M. Sugrue. Mary M. Sugrue is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 8 | |
| 2 | 2 | |
| 3 | 27 | |
| 4 | 1 | |
| 5 | 7 | |
| 6 | 4 | |
| 7 | 1 | |
| 8 | 10 | |
| 9 | 131 | |
| 10 | 16 | |
| 11 | Bevacizumab Beyond First Progression Is Associated With Prolonged Overall Survival in Metastatic Colorectal Cancer: Results From a Large Observational Cohort Study (BRiTE)breakdown → | 519 |
| 12 | 7 | |
| 13 | 52 | |
| 14 | 10 | |
| 15 | 52 | |
| 16 | 81 | |
| 17 | 30 | |
| 18 | 168 | |
| 19 | Inhibition of tumor cell growth by RTP/rit42 and its responsiveness to p53 and DNA damage. | 225 |
| 20 | 34 |
About Mary M. Sugrue
Mary M. Sugrue is a scholar working on Hematology, Genetics and Occupational Therapy, having authored 48 papers that have together received 2.2k indexed citations. Recurring topics across this work include Colorectal Cancer Treatments and Studies (16 papers), Acute Myeloid Leukemia Research (15 papers) and Cancer Treatment and Pharmacology (12 papers). The work is most often cited by research in Oncology (1.3k citations), Hepatology (296 citations) and Geriatrics and Gerontology (108 citations). Mary M. Sugrue has collaborated with scholars based in United States, France and Germany. Frequent co-authors include Stuart A. Aaronson, Axel Grothey, Mark Kozloff, Wei Dong, David M. Purdie, Sam W. Lee, Eric Hedrick, Daniel J. Sargent, Deug Y. Shin and Patrick J. Flynn. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.